254 related articles for article (PubMed ID: 16086941)
21. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
22. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Bagur R; Proulx G; Gleeton O; Costerousse O; De Larochellière R; Roy L
Am J Cardiol; 2009 Nov; 104(9):1235-40. PubMed ID: 19840568
[TBL] [Abstract][Full Text] [Related]
23. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
[TBL] [Abstract][Full Text] [Related]
25. Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting.
Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2011 Oct; 124(19):3022-9. PubMed ID: 22040548
[TBL] [Abstract][Full Text] [Related]
26. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
[TBL] [Abstract][Full Text] [Related]
27. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
28. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
[TBL] [Abstract][Full Text] [Related]
29. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
[TBL] [Abstract][Full Text] [Related]
30. Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.
Iijima R; Ndrepepa G; Mehilli J; Dirschinger J; Pache J; Seyfarth M; Schömig A; Kastrati A
Am J Cardiol; 2008 May; 101(9):1226-31. PubMed ID: 18435948
[TBL] [Abstract][Full Text] [Related]
31. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting.
Yip HK; Hung WC; Yang CH; Chen YH; Cheng CI; Chen SM; Yeh KH
Circ J; 2005 Oct; 69(10):1202-7. PubMed ID: 16195617
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
[TBL] [Abstract][Full Text] [Related]
33. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
[TBL] [Abstract][Full Text] [Related]
34. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
[TBL] [Abstract][Full Text] [Related]
35. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
[TBL] [Abstract][Full Text] [Related]
36. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
[TBL] [Abstract][Full Text] [Related]
37. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Sick PB; Brosteanu O; Ulrich M; Thiele H; Niebauer J; Busch I; Schuler G
Am Heart J; 2005 Apr; 149(4):681-8. PubMed ID: 15990753
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
[TBL] [Abstract][Full Text] [Related]
39. [Eosinophilic cation protein and development of restenosis of drug covered stents].
Gabbasov ZA; Kozlov SG; Saburova OS; Imaeva AÉ; Bosykh EG; Liakishev AA; Zykov KA; Masenko VP
Kardiologiia; 2011; 51(6):49-54. PubMed ID: 21878071
[TBL] [Abstract][Full Text] [Related]
40. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
